The canadian hypertension education program (CHEP) 2011 guidelines for pharmacists

Canadian Pharmacists Journal

Volumn 144, Issue 6, 2011, Pages 295-304

  Houle, Sherilyn K D ^a   Tsuyuki, Ross T ^a   Campbell, Norman R C ^b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLOOD PRESSURE MONITORING; CARDIOVASCULAR RISK; EDUCATION PROGRAM; FOLLOW UP; HEALTH CARE PLANNING; HEALTH EDUCATION; HOME CARE; HUMAN; HYPERTENSION; LIFESTYLE MODIFICATION; PATIENT COMPLIANCE; PATIENT EDUCATION; PHARMACIST ATTITUDE; PRIMARY MEDICAL CARE; RISK ASSESSMENT;

EID: 80955148169     PISSN: 17151635     EISSN: 1913701X     Source Type: Journal    
DOI: 10.3821/1913-701X-144.6.295     Document Type: Article

References (17)

1. Wilkins K, Campbell N, Joffres M, et al. Blood pressure in Canadian adults. Health Reports 2010;21:1-10.
2. Kearney PM, Whelton M, Reynolds K, et al. Worldwide prevalence of hypertension: a systematic review. J Hypertens 2004;22:11-19.
3. Egan BM, Zhao Y, Axon RN. US trends in prevalence, awareness, treatment and control of hypertension, 1988-2008. JAMA 2010;303:2043-50.
4. McLean DL, McAlister FA, Johnson J, et al. A randomized trial of the effect of community pharmacist and nurse care on improving blood pressure management in patients with diabetes mellitus: Study of Cardiovascular Risk Intervention by Pharmacists-Hypertension (SCRIP-HTN). Arch Intern Med 2008;168(21):2355-61.
5. Tobari H, Arimoto T, Shimojo N, et al. Physician-pharmacist cooperation program for blood pressure control in patients with hypertension: a randomized-controlled trial. Am J Hypertens 2010;23(10):1144-52.
6. Weber CA, Ernst ME, Sezate GS, et al. Pharmacist-physician comanagement of hypertension and reduction in 24-hour ambulatory blood pressures. Arch Intern Med 2010;170(18):1634-9.
7. Carter BL, Ardery G, Dawson JD, et al. Physician and pharmacist collaboration to improve blood pressure control. Arch Intern Med 2009;169(21):1996-2002.
8. Hunt JS, Siemienczuk J, Pape G, et al. A randomized controlled trial of team- based care: impact of physician-pharmacist collaboration on uncontrolled hypertension. J Gen Intern Med 2008;23(12):1966-72.
9. Machado M, Bajcar J, Guzzo GC, Einarson TR. Sensitivity of patient out comes to pharmacist interventions. Part II: Systematic review and meta-analysis in hypertension management. Ann Pharmacother 2007;41(11):1770-81.
10. Rabi DM, Daskalopoulou SS, Padwal RS, et al. on behalf of the Canadian Hypertension Education Program. The 2011 Canadian Hypertension Education Program recommendations for the management of hypertension: blood pressure measurement, diagnosis, assessment of risk, and therapy. Can J Cardiol 2011;27(4):415-33.
11. Canadian Diabetes Association Clinical Practice Guidelines Expert Commit-tee. Canadian Diabetes Association 2008 clinical practice guidelines for the prevention and management of diabetes in Canada. Can J Diabetes 2008;32(suppl 1):S1-S201.
12. Genest J, McPherson R, Frolich J, et al. 2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult 2009 recommendations. Can J Cardiol 2009;25(10):567-79.
13. National Institutes of Health. DASH eating plan your guide to lowering your blood pressure with DASH. Available: www.nhlbi.nih.gov/health/public/heart/hbp/dash/new_dash.pdf (accessed Oct.6, 2011).
14. Leonardi-Bee J, Bath PMW, Phillips SJ, Sandercock PAG. Blood pressure and clinical outcomes in the International Stroke Trial. Stroke 2002;33:1315-20.
15. Lindsay MP, Gubitz G, Bayley M, Hill MD, Davies-Schinkel C, Singh S, et al. Canadian Best Practice Recommendations for Stroke Care (Update 2010). Canadian Stroke Network, 2010.
16. Sipahi I, Debanne S, Rowland D, Simon D, Fang J. Angiotensin-receptor blockade and risk of cancer: meta-analysis of randomized controlled trials. Lancet Oncology 2010;11(7):627-36.
17. Cushman W, Evans G, Byington R, Goff D, Grimm R, Cutler J, et al. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med 2010;10:1286-97.